LumiraDx seeks FDA EUA for SARS-CoV-2 & Flu A/B test
The rapid microfluidic immunofluorescence assay will facilitate the simultaneous identification of SARS-CoV-2, Influenza A, and Influenza B viral…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Oct 21
The rapid microfluidic immunofluorescence assay will facilitate the simultaneous identification of SARS-CoV-2, Influenza A, and Influenza B viral…
18 Oct 21
The new plus version of the test provides a third gene target for SARS-CoV-2 detection to meet the…
18 Oct 21
The V8 was recently cleared by the U.S. Food and Drug Administration for commercial use in the USA.…
12 Oct 21
By using gamification and buddy system techniques, the new solution is said to guide young children through the…
12 Oct 21
By using the Quanterix HD-X immunoassay system, the blood-based assay will measure the pTau-181 concentration in human serum…
12 Oct 21
This test kit uses a reagent developed using Kaneka's molecular testing-related technologies. The reagent makes it possible to…
12 Oct 21
The collaboration leverages the strengths of Invitae, which supplies clinical grade genetic testing, and Outcomes4Me’s 360-degree, validated and…
11 Oct 21
The Indian Council for Medical Research (ICMR) has already transferred the new technology to two companies, which are…
11 Oct 21
The system features Speed Up technology for optimal image quality in reduced examination times and True-Motion real-time imaging…
11 Oct 21
Kaneka’s PCR test kit is capable of detecting four variants including, Alpha, Delta, Kappa, and Beta or Gamma…